Prakash Investment Advisors LLC Purchases Shares of 1,800 Axon Enterprise, Inc. (NASDAQ:AXON)

Prakash Investment Advisors LLC purchased a new stake in Axon Enterprise, Inc. (NASDAQ:AXON) during the 4th quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The institutional investor purchased 1,800 shares of the biotechnology company’s stock, valued at approximately $1,070,000. Axon Enterprise makes up about 1.1% of Prakash Investment Advisors LLC’s investment portfolio, making the stock its 17th largest holding.

Several other institutional investors and hedge funds also recently modified their holdings of the business. Geode Capital Management LLC lifted its holdings in shares of Axon Enterprise by 2.0% in the third quarter. Geode Capital Management LLC now owns 1,782,828 shares of the biotechnology company’s stock valued at $710,103,000 after purchasing an additional 35,320 shares in the last quarter. Westfield Capital Management Co. LP lifted its holdings in shares of Axon Enterprise by 12.2% in the third quarter. Westfield Capital Management Co. LP now owns 1,175,328 shares of the biotechnology company’s stock valued at $469,661,000 after purchasing an additional 127,769 shares in the last quarter. Champlain Investment Partners LLC lifted its holdings in shares of Axon Enterprise by 13.9% in the third quarter. Champlain Investment Partners LLC now owns 682,420 shares of the biotechnology company’s stock valued at $272,695,000 after purchasing an additional 83,265 shares in the last quarter. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC lifted its holdings in shares of Axon Enterprise by 1.6% in the third quarter. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC now owns 561,263 shares of the biotechnology company’s stock valued at $224,281,000 after purchasing an additional 9,090 shares in the last quarter. Finally, Groupama Asset Managment purchased a new stake in shares of Axon Enterprise in the third quarter valued at about $200,000. Hedge funds and other institutional investors own 79.08% of the company’s stock.

Insider Buying and Selling

In other news, insider Jeffrey C. Kunins sold 2,304 shares of the stock in a transaction on Tuesday, December 3rd. The shares were sold at an average price of $654.79, for a total value of $1,508,636.16. Following the completion of the sale, the insider now owns 128,542 shares of the company’s stock, valued at $84,168,016.18. This represents a 1.76 % decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this hyperlink. Also, Director Caitlin Elizabeth Kalinowski sold 450 shares of the stock in a transaction on Thursday, January 2nd. The stock was sold at an average price of $604.07, for a total transaction of $271,831.50. Following the completion of the sale, the director now directly owns 6,929 shares of the company’s stock, valued at $4,185,601.03. The trade was a 6.10 % decrease in their position. The disclosure for this sale can be found here. Over the last quarter, insiders sold 8,711 shares of company stock valued at $5,631,561. Insiders own 6.10% of the company’s stock.

Analyst Ratings Changes

Several analysts have issued reports on AXON shares. Craig Hallum downgraded shares of Axon Enterprise from a “buy” rating to a “hold” rating and set a $625.00 price target on the stock. in a report on Thursday. Needham & Company LLC boosted their price objective on shares of Axon Enterprise from $525.00 to $600.00 and gave the company a “buy” rating in a research report on Friday, November 8th. The Goldman Sachs Group boosted their price objective on shares of Axon Enterprise from $500.00 to $700.00 and gave the company a “buy” rating in a research report on Monday, January 27th. Northcoast Research lowered shares of Axon Enterprise from a “buy” rating to a “neutral” rating in a research report on Wednesday. Finally, Northland Securities boosted their price objective on shares of Axon Enterprise from $365.00 to $550.00 and gave the company an “outperform” rating in a research report on Monday, November 11th. Three investment analysts have rated the stock with a hold rating and thirteen have given a buy rating to the stock. According to MarketBeat, the stock presently has a consensus rating of “Moderate Buy” and an average price target of $561.31.

Axon Enterprise Stock Performance

Shares of AXON stock opened at $540.00 on Friday. Axon Enterprise, Inc. has a one year low of $260.27 and a one year high of $715.99. The company has a debt-to-equity ratio of 0.32, a quick ratio of 2.63 and a current ratio of 2.96. The company has a 50 day moving average price of $622.57 and a 200 day moving average price of $515.53. The firm has a market capitalization of $41.18 billion, a price-to-earnings ratio of 139.54, a price-to-earnings-growth ratio of 5.95 and a beta of 1.05.

About Axon Enterprise

Axon Enterprise, Inc develops, manufactures, and sells conducted energy devices (CEDs) under the TASER brand in the United States and internationally. It operates through two segments, Software and Sensors, and TASER. The company also offers hardware and cloud-based software solutions that enable law enforcement to capture, securely store, manage, share, and analyze video and other digital evidence.